Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 36,623 |
|
|||||
| News | - | ||||||
| Day High | 7.3696 | Low High |
|||||
| Day Low | 6.90 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Nuvectis Pharma Inc | NVCT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.5501 | 8.14% | 7.3101 | 11:52:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.93 | 6.90 | 7.3696 | 6.76 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 686 | 36,623 | US$ 7.10 | US$ 259,870 | - | 5.92 - 18.65 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:52:58 | 423 | US$ 7.3101 | USD |
Nuvectis Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 129.89M | 17.77M | - | 0 | -22.26M | -1.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nuvectis Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/05/2024 | 16:20 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 3/05/2024 | 07:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/05/2024 | 15:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/05/2024 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/08/2023 | 07:39 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/08/2023 | 06:45 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 9/12/2023 | 07:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/17/2023 | 08:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/09/2023 | 15:51 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 8/09/2023 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/09/2023 | 15:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 7/03/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVCT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.52 | 7.3696 | 5.92 | 6.31 | 99,684 | 0.7901 | 12.12% |
| 1 Month | 7.82 | 8.03 | 5.92 | 6.66 | 64,853 | -0.5099 | -6.52% |
| 3 Months | 6.99 | 12.10 | 5.92 | 8.50 | 100,574 | 0.3201 | 4.58% |
| 6 Months | 9.12 | 12.10 | 5.92 | 8.34 | 80,723 | -1.81 | -19.85% |
| 1 Year | 14.75 | 18.65 | 5.92 | 11.10 | 68,386 | -7.44 | -50.44% |
| 3 Years | 3.95 | 20.92 | 3.08 | 8.03 | 208,091 | 3.36 | 85.07% |
| 5 Years | 3.95 | 20.92 | 3.08 | 8.03 | 208,091 | 3.36 | 85.07% |
Nuvectis Pharma Description
| Nuvectis Pharma Inc is a biopharmaceutical company. |
